블로그
-
Antibody–Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor ...
systemic PARP and TOP1 inhibitors failed due to dose-limiting myelosuppression. Here, we assess the proof-of-mechanism and c.......
blog.naver.com · 2025.12.21
-
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer...
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer models resistance in both HR+ and TNBC models.
blog.naver.com · 2025.08.15
-
Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer
, breast cancer is the most prevalent form of a malignant tumour. Among the subtypes of breast cancer, hormone receptor (HR) positive and human epidermal growth factor
blog.naver.com · 2025.11.02
-
미세혈뇨의 임상 가이드라인
June; 66(6):343-347, 2) https://www.urotoday.com/conference-highlights/suo-2025/suo-2025-bladder-cancer /165252-suo-2025-the-2025-aua-hematuria-guidelines-overview-of-recommendations-and-risk-stratification.html
blog.naver.com · 2026.01.05
-
CDK7은 HNSCC의 Achilles heel
Patient-Derived Organoid & Cancer Stem Cell 9. CDK7이 Achilles Heel인 이유 10. 임상적 함의 및 향후 전망 11. Introduction 두경부 편평세포암(HNSCC)의 임상적 한계 두경부 편평세포암(HNSCC, Head and Neck Squamous Cell Carcinoma)은 전세계에서
blog.naver.com · 2026.01.02
-
Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition
and DNA damage repair pathways. These findings offered a novel therapeutic strategy to enhance cancer susceptibi.......
blog.naver.com · 2025.11.28
-
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find ...
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them /6i) have significantly impacted on the treatment of HR + HER2 negative (HER2-) metastatic breast cancer
blog.naver.com · 2025.11.09
-
[보도자료] <한국백혈병환우회> 단체명, <한국백혈병혈액암환우회>로 변경
;wr_id=90 [보도자료] 단체명, 로 변경 한국백혈병환우회(공동대표 안기종·이은영)가 2025년 11월 7일부로 단체명을 ‘한국백혈병혈액암환우회(Korea Leukemia and Blood Cancer Patients Organization · KLBPO)’로 변경했다.
blog.naver.com · 2025.11.18
-
발효 밀배아 추출물(Avemar), 진행성 두경부암 환자의 삶의 질을 높이다
— 산화 스트레스 감소와 통합 암 치료의 새로운 가능성 두경부암(head and neck cancer)은 음식 섭취, 발음, 호흡 등 기본적인 삶의 기능에 직접적인 영향을 주는 질환입니다 연구 개요: 통합 암 치료에서의 Avemar 역할 연구팀: Sukkar SG 외 논문 출처: Mediterranean Journal of Nutrition and Metabolism
blog.naver.com · 2025.11.10
-
ASSOCIATION BETWEEN PRIVATE WELL WATER EXPOSURE AND PROSTATE CANCER SEVERITY
ASSOCIATION BETWEEN PRIVATE WELL WATER EXPOSURE AND PROSTATE CANCER SEVERITY: ANALYSIS OF A NATIONAL COHORT OF PATIENTS FROM 2010-2017 Introduction Prostate cancer is one of the most commonly diagnosed
blog.naver.com · 2025.06.13
